ArticleScientific reports2024

Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation.

Ayana Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.